uric acid has been researched along with Gestational Hypertension in 34 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The association between uric acid (UA) and pre-eclampsia has been known for years, but the prognostic value of UA has been debated." | 8.88 | Serum uric acid and pre-eclampsia: an update. ( Bellomo, G, 2012) |
| " In women with pre-eclampsia, a positive test result of uric acid greater than or equal to a 350-micromol/l threshold predicted eclampsia with a pooled likelihood ratio (LR) of 2." | 8.83 | Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. ( Coomarasamy, A; Ismail, KM; Khan, KS; Sharp, S; Thangaratinam, S, 2006) |
| "This study aims to ascertain whether serum uric acid is a suitable predictor of preeclampsia and/or the delivery of small-for-gestational-age infants for women with gestational hypertension." | 8.02 | Uric acid levels in gestational hypertensive women predict preeclampsia and outcome of small-for-gestational-age infants. ( Duan, T; Frempong, ST; Zhao, X, 2021) |
| " In our previous study, we showed that serum strontium (Sr) levels were elevated in preeclamptic women compared to healthy and GH pregnant women at the end of pregnancy." | 7.91 | Increased serum strontium levels and altered oxidative stress status in early-onset preeclampsia. ( Álvarez, FV; Barneo-Caragol, C; Lequerica-Fernández, P; Martínez-Morillo, E; Rodríguez-González, S; Vega-Naredo, I, 2019) |
| "To assess the relationship between maternal serum uric acid and severity of Hypertensive disorders of pregnancy in a rural tertiary care centre." | 7.91 | Maternal Serum Uric Acid as a Predictor of Severity of Hypertensive Disorders of Pregnancy: A Prospective Cohort Study. ( Kumar, N; Singh, AK, 2019) |
| "This study aims to investigate the clinical value of uric acid in predicting adverse pregnancy outcomes (APOs) of women with hypertensive disorders of pregnancy." | 7.88 | The value of serum uric acid in predicting adverse pregnancy outcomes of women with hypertensive disorders of pregnancy. ( Hong, XY; Lin, J; Tu, RZ, 2018) |
| " Mean serum uric acid in gestational hypertension women with healthy foetuses was 5." | 7.85 | Impact of maternal serum uric acid on perinatal outcome in women with hypertensive disorders of pregnancy: A prospective study. ( Kumar, N; Maini, B; Singh, AK, 2017) |
| "We asked, is uric acid as effective as proteinuria at identifying perinatal risk in high-risk women with gestational hypertension? Uric acid was measured in samples obtained ≈4." | 7.81 | Uric Acid Determination in Gestational Hypertension: Is it as Effective a Delineator of Risk as Proteinuria in High-Risk Women? ( Althouse, AD; Clifton, RG; Roberts, JM; Schmella, MJ, 2015) |
| "Decades after pregnancy, women who had an HPD have higher uric acid concentrations." | 7.81 | Uric Acid: A Missing Link Between Hypertensive Pregnancy Disorders and Future Cardiovascular Disease? ( Asad, RA; Garovic, VD; Hanis, CL; Kardia, SL; Milic, NM; Mosley, TH; Turner, ST; Weissgerber, TL, 2015) |
| " Women were grouped according to diagnosis (pre-eclampsia or gestational hypertension) and logistic regression analysis was used to determine the relationship between uric acid, haemoglobin, haematocrit and adverse outcomes; an α level of P < 0." | 7.78 | Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. ( Brown, MA; Davis, GK; Hawkins, TL; Mangos, GJ; Roberts, JM; Roberts, LM, 2012) |
| "Higher serum uric acid levels at the initial presentation of gestational hypertension may indicate heightened risk of progression to preeclampsia and development of adverse maternal/infant conditions." | 7.78 | Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies. ( Fraser, WD; Luo, ZC; Wu, Y; Xiong, X, 2012) |
| "The association of elevated serum uric acid with the development of hypertension is established outside of pregnancy." | 7.77 | First trimester uric acid and adverse pregnancy outcomes. ( Catov, J; Gandley, RE; Laughon, SK; Powers, RW; Roberts, JM, 2011) |
| "Aim of our study was to ascertain, prospectively, whether serum uric acid is a suitable predictor of preeclampsia and/or the delivery of small-for-gestational-age infants in women with gestational hypertension." | 7.77 | Prognostic significance of serum uric acid in women with gestational hypertension. ( Bellomo, G; Narducci, PL; Saronio, P; Venanzi, S; Verdura, C, 2011) |
| "We sought to investigate whether uric acid concentrations are increased in pregnant women with insulin resistance and to correlate both with fetal growth." | 7.75 | Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women. ( Catov, J; Laughon, SK; Roberts, JM, 2009) |
| "The purpose of this study was to assess a possible correlation between insulin resistance and uric acid levels in gestational hypertension (GH) and preeclampsia." | 7.73 | Elevated serum uric acid levels in gestational hypertension are correlated with insulin resistance. ( Cohen, O; Homko, CJ; Schiff, E; Sivan, E; Weisz, B, 2005) |
| "Preeclampsia is one of the most severe diseases among the hypertensive disorders of pregnancy (HDP) and the leading cause of maternal and fetal morbidity and mortality." | 5.91 | Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes. ( Agnoletti, D; Baracchi, A; Borghi, C; Degli Esposti, D; Montaguti, E; Piani, F; Scarduelli, S; Simonazzi, G; Tossetta, G; Verde, C, 2023) |
| "The control group included women with gestational hypertension (GH, n = 56) and healthy pregnancies (samples collected in the 1st (n = 50), 2nd (n = 51) and 3rd trimesters (n = 53))." | 5.48 | Strontium and its role in preeclampsia. ( Álvarez Menéndez, FV; Barneo-Caragol, C; Lequerica-Fernández, P; Martínez-Morillo, E; Rodríguez-González, S; Vega-Naredo, I, 2018) |
| " In the setting of hypertensive disorders of pregnancy, oral antihypertensive medications should be initiated when systolic blood pressure is greater than 160 mm Hg or when diastolic blood pressure is greater than 110 mm Hg, with the most ideal agents being labetalol or nifedipine." | 5.22 | Hypertensive Disorders of Pregnancy: Common Clinical Conundrums. ( Dotters-Katz, S; Kuller, JA; Lim, SL; Ohamadike, O; Siegel, A; Zemtsov, G, 2022) |
| "The association between uric acid (UA) and pre-eclampsia has been known for years, but the prognostic value of UA has been debated." | 4.88 | Serum uric acid and pre-eclampsia: an update. ( Bellomo, G, 2012) |
| " In women with pre-eclampsia, a positive test result of uric acid greater than or equal to a 350-micromol/l threshold predicted eclampsia with a pooled likelihood ratio (LR) of 2." | 4.83 | Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. ( Coomarasamy, A; Ismail, KM; Khan, KS; Sharp, S; Thangaratinam, S, 2006) |
| "This study aims to ascertain whether serum uric acid is a suitable predictor of preeclampsia and/or the delivery of small-for-gestational-age infants for women with gestational hypertension." | 4.02 | Uric acid levels in gestational hypertensive women predict preeclampsia and outcome of small-for-gestational-age infants. ( Duan, T; Frempong, ST; Zhao, X, 2021) |
| "To assess the relationship between maternal serum uric acid and severity of Hypertensive disorders of pregnancy in a rural tertiary care centre." | 3.91 | Maternal Serum Uric Acid as a Predictor of Severity of Hypertensive Disorders of Pregnancy: A Prospective Cohort Study. ( Kumar, N; Singh, AK, 2019) |
| " In our previous study, we showed that serum strontium (Sr) levels were elevated in preeclamptic women compared to healthy and GH pregnant women at the end of pregnancy." | 3.91 | Increased serum strontium levels and altered oxidative stress status in early-onset preeclampsia. ( Álvarez, FV; Barneo-Caragol, C; Lequerica-Fernández, P; Martínez-Morillo, E; Rodríguez-González, S; Vega-Naredo, I, 2019) |
| "This study aims to investigate the clinical value of uric acid in predicting adverse pregnancy outcomes (APOs) of women with hypertensive disorders of pregnancy." | 3.88 | The value of serum uric acid in predicting adverse pregnancy outcomes of women with hypertensive disorders of pregnancy. ( Hong, XY; Lin, J; Tu, RZ, 2018) |
| " Mean serum uric acid in gestational hypertension women with healthy foetuses was 5." | 3.85 | Impact of maternal serum uric acid on perinatal outcome in women with hypertensive disorders of pregnancy: A prospective study. ( Kumar, N; Maini, B; Singh, AK, 2017) |
| "We asked, is uric acid as effective as proteinuria at identifying perinatal risk in high-risk women with gestational hypertension? Uric acid was measured in samples obtained ≈4." | 3.81 | Uric Acid Determination in Gestational Hypertension: Is it as Effective a Delineator of Risk as Proteinuria in High-Risk Women? ( Althouse, AD; Clifton, RG; Roberts, JM; Schmella, MJ, 2015) |
| "Decades after pregnancy, women who had an HPD have higher uric acid concentrations." | 3.81 | Uric Acid: A Missing Link Between Hypertensive Pregnancy Disorders and Future Cardiovascular Disease? ( Asad, RA; Garovic, VD; Hanis, CL; Kardia, SL; Milic, NM; Mosley, TH; Turner, ST; Weissgerber, TL, 2015) |
| " Significant changes of biochemical parameters in cases of hypertensive disorders in pregnancy are increased levels of blood glucose, urea, creatinine, uric acid (hyperuricemia), transaminases, and LDH." | 3.79 | Correlation of biochemical parameters and neonatal outcome in patients with gestational hypertension. ( Aksam, S; Kocijancic, A; Kocijancic, DM; Plecas, D; Plesinac, S, 2013) |
| " Women were grouped according to diagnosis (pre-eclampsia or gestational hypertension) and logistic regression analysis was used to determine the relationship between uric acid, haemoglobin, haematocrit and adverse outcomes; an α level of P < 0." | 3.78 | Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. ( Brown, MA; Davis, GK; Hawkins, TL; Mangos, GJ; Roberts, JM; Roberts, LM, 2012) |
| "Higher serum uric acid levels at the initial presentation of gestational hypertension may indicate heightened risk of progression to preeclampsia and development of adverse maternal/infant conditions." | 3.78 | Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies. ( Fraser, WD; Luo, ZC; Wu, Y; Xiong, X, 2012) |
| "The association of elevated serum uric acid with the development of hypertension is established outside of pregnancy." | 3.77 | First trimester uric acid and adverse pregnancy outcomes. ( Catov, J; Gandley, RE; Laughon, SK; Powers, RW; Roberts, JM, 2011) |
| "Aim of our study was to ascertain, prospectively, whether serum uric acid is a suitable predictor of preeclampsia and/or the delivery of small-for-gestational-age infants in women with gestational hypertension." | 3.77 | Prognostic significance of serum uric acid in women with gestational hypertension. ( Bellomo, G; Narducci, PL; Saronio, P; Venanzi, S; Verdura, C, 2011) |
| "Gestational age at first presentation < 32 weeks, gestation-standardised blood pressure parameters and serum uric acid were more predictive of the development of preeclampsia, delivery before 34 weeks, severe hypertension and fetal growth restriction than absolute values." | 3.76 | Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension. ( Anumba, DO; Lincoln, K; Robson, SC, 2010) |
| "We sought to investigate whether uric acid concentrations are increased in pregnant women with insulin resistance and to correlate both with fetal growth." | 3.75 | Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women. ( Catov, J; Laughon, SK; Roberts, JM, 2009) |
| "The purpose of this study was to assess a possible correlation between insulin resistance and uric acid levels in gestational hypertension (GH) and preeclampsia." | 3.73 | Elevated serum uric acid levels in gestational hypertension are correlated with insulin resistance. ( Cohen, O; Homko, CJ; Schiff, E; Sivan, E; Weisz, B, 2005) |
| "Serum uric acid levels, plasma protein C (PC), protein S (PS), antithrombin III (AT III) activities and activated protein C resistance (APCR) were measured in 80 pregnant women with hypertension (preeclampsia, n = 32; severe preeclampsia, n = 25; eclampsia, n = 14; chronic hypertension, n = 9) and 58 healthy pregnant women." | 3.73 | Evaluation of natural coagulation inhibitor levels in various hypertensive states of pregnancy. ( Sayin, M; Sayin, NC; Varol, FG, 2005) |
| "Preeclampsia is one of the most severe diseases among the hypertensive disorders of pregnancy (HDP) and the leading cause of maternal and fetal morbidity and mortality." | 1.91 | Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes. ( Agnoletti, D; Baracchi, A; Borghi, C; Degli Esposti, D; Montaguti, E; Piani, F; Scarduelli, S; Simonazzi, G; Tossetta, G; Verde, C, 2023) |
| "The control group included women with gestational hypertension (GH, n = 56) and healthy pregnancies (samples collected in the 1st (n = 50), 2nd (n = 51) and 3rd trimesters (n = 53))." | 1.48 | Strontium and its role in preeclampsia. ( Álvarez Menéndez, FV; Barneo-Caragol, C; Lequerica-Fernández, P; Martínez-Morillo, E; Rodríguez-González, S; Vega-Naredo, I, 2018) |
| "Although gestational hypertension (GH) is thought to be different from preeclampsia (PE), in Japan GH and PE are usually treated as the same disease (i." | 1.46 | Comparison of Kidney Function between Gestational Hypertension and Preeclampsia. ( Eguchi, T; Eto, E; Hayata, K; Hiramatsu, Y; Maki, J; Masuyama, H; Mitsui, T; Nobumoto, E; Tamada, S, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (26.47) | 29.6817 |
| 2010's | 22 (64.71) | 24.3611 |
| 2020's | 3 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Ohamadike, O | 1 |
| Lim, SL | 1 |
| Siegel, A | 1 |
| Zemtsov, G | 1 |
| Kuller, JA | 1 |
| Dotters-Katz, S | 1 |
| Piani, F | 1 |
| Agnoletti, D | 1 |
| Baracchi, A | 1 |
| Scarduelli, S | 1 |
| Verde, C | 1 |
| Tossetta, G | 1 |
| Montaguti, E | 1 |
| Simonazzi, G | 1 |
| Degli Esposti, D | 2 |
| Borghi, C | 2 |
| Chescheir, NC | 1 |
| Zhao, X | 1 |
| Frempong, ST | 1 |
| Duan, T | 1 |
| Nobumoto, E | 1 |
| Masuyama, H | 1 |
| Maki, J | 1 |
| Eguchi, T | 1 |
| Tamada, S | 1 |
| Mitsui, T | 1 |
| Eto, E | 1 |
| Hayata, K | 1 |
| Hiramatsu, Y | 1 |
| Kumar, N | 2 |
| Singh, AK | 2 |
| Maini, B | 1 |
| Zhou, G | 1 |
| Holzman, C | 1 |
| Luo, Z | 1 |
| Margerison, C | 1 |
| Barneo-Caragol, C | 2 |
| Martínez-Morillo, E | 2 |
| Rodríguez-González, S | 2 |
| Lequerica-Fernández, P | 2 |
| Vega-Naredo, I | 2 |
| Álvarez Menéndez, FV | 1 |
| Lin, J | 1 |
| Hong, XY | 1 |
| Tu, RZ | 1 |
| Álvarez, FV | 1 |
| Yamada, T | 2 |
| Ishikawa, S | 1 |
| Kataoka, S | 1 |
| Uda, T | 1 |
| Iinuma, Y | 1 |
| Hattori, R | 1 |
| Morikawa, M | 1 |
| Kaneuchi, M | 1 |
| Minakami, H | 1 |
| Gyselaers, W | 1 |
| Tomsin, K | 1 |
| Staelens, A | 1 |
| Mesens, T | 1 |
| Oben, J | 1 |
| Molenberghs, G | 1 |
| Schmella, MJ | 1 |
| Clifton, RG | 1 |
| Althouse, AD | 1 |
| Roberts, JM | 4 |
| Cicero, AF | 1 |
| Immordino, V | 1 |
| Morbini, M | 1 |
| Baronio, C | 1 |
| Rosticci, M | 1 |
| Weissgerber, TL | 1 |
| Milic, NM | 1 |
| Turner, ST | 1 |
| Asad, RA | 1 |
| Mosley, TH | 1 |
| Kardia, SL | 1 |
| Hanis, CL | 1 |
| Garovic, VD | 1 |
| Inoue, M | 1 |
| Tsuchihashi, T | 1 |
| Hasuo, Y | 1 |
| Ogawa, M | 1 |
| Tominaga, M | 1 |
| Arakawa, K | 1 |
| Oishi, E | 1 |
| Sakata, S | 1 |
| Ohtsubo, T | 1 |
| Matsumura, K | 1 |
| Kitazono, T | 1 |
| Paula, LG | 1 |
| da Costa, BE | 1 |
| Poli-de-Figueiredo, CE | 1 |
| Antonello, IC | 1 |
| Laughon, SK | 2 |
| Catov, J | 2 |
| Ahaneku, JE | 1 |
| Adinma, JI | 1 |
| Ahaneku, GI | 1 |
| Nwosu, BO | 1 |
| Nwofor, PC | 1 |
| Okoli, CC | 1 |
| Anumba, DO | 1 |
| Lincoln, K | 1 |
| Robson, SC | 1 |
| Powers, RW | 1 |
| Gandley, RE | 1 |
| Bellomo, G | 2 |
| Venanzi, S | 1 |
| Saronio, P | 1 |
| Verdura, C | 1 |
| Narducci, PL | 1 |
| Johnson, RJ | 2 |
| Kanbay, M | 1 |
| Kang, DH | 1 |
| Sánchez-Lozada, LG | 1 |
| Feig, D | 1 |
| Hawkins, TL | 1 |
| Mangos, GJ | 1 |
| Davis, GK | 1 |
| Roberts, LM | 1 |
| Brown, MA | 1 |
| Wu, Y | 1 |
| Xiong, X | 1 |
| Fraser, WD | 1 |
| Luo, ZC | 1 |
| Kocijancic, DM | 1 |
| Plesinac, S | 1 |
| Plecas, D | 1 |
| Aksam, S | 1 |
| Kocijancic, A | 1 |
| Gojnic, M | 1 |
| Pervulov, M | 1 |
| Petkovic, S | 1 |
| Mostic, T | 1 |
| Adamsons, K | 1 |
| Papic, M | 1 |
| Jeremic, K | 1 |
| Weisz, B | 1 |
| Cohen, O | 1 |
| Homko, CJ | 1 |
| Schiff, E | 1 |
| Sivan, E | 1 |
| Sayin, M | 1 |
| Varol, FG | 1 |
| Sayin, NC | 1 |
| Thadhani, RI | 1 |
| Karumanchi, SA | 1 |
| Thangaratinam, S | 1 |
| Ismail, KM | 1 |
| Sharp, S | 1 |
| Coomarasamy, A | 1 |
| Khan, KS | 1 |
| Peraçoli, JC | 1 |
| Rudge, MV | 1 |
| Peraçoli, MT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Association of Maternal Uric Acid With Maternal Condition and Fetal Outcome in Pregnant Women With Hypertension[NCT01523327] | 80 participants (Anticipated) | Observational | 2011-10-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for uric acid and Gestational Hypertension
| Article | Year |
|---|---|
Hypertensive Disorders of Pregnancy: Common Clinical Conundrums.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; P | 2022 |
Serum uric acid and pre-eclampsia: an update.
Topics: Animals; Female; Humans; Hypertension, Pregnancy-Induced; Pre-Eclampsia; Pregnancy; Pregnancy Outcom | 2012 |
Hypertension during pregnancy: a disorder begging for pathophysiological support.
Topics: Eclampsia; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Pre-Eclampsia; Pregnancy; | 2005 |
Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.
Topics: Biomarkers; Cesarean Section; Female; Fetal Growth Retardation; HELLP Syndrome; Humans; Hypertension | 2006 |
1 trial available for uric acid and Gestational Hypertension
| Article | Year |
|---|---|
Salt Intake, Home Blood Pressure, and Perinatal Outcome in Pregnant Women.
Topics: Adult; Age Factors; Body Mass Index; Female; Humans; Hypertension, Pregnancy-Induced; Pregnancy; Pre | 2016 |
29 other studies available for uric acid and Gestational Hypertension
| Article | Year |
|---|---|
Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes.
Topics: Creatinine; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Pre-Eclampsia; Pregnan | 2023 |
Serum Uric Acid Measurement in Women With Hypertensive Disorders of Pregnancy.
Topics: Adult; Female; Humans; Hypertension, Pregnancy-Induced; Pre-Eclampsia; Pregnancy; Risk Factors; Uric | 2019 |
Uric acid levels in gestational hypertensive women predict preeclampsia and outcome of small-for-gestational-age infants.
Topics: Female; Humans; Hypertension, Pregnancy-Induced; Infant; Infant, Newborn; Infant, Small for Gestatio | 2021 |
Comparison of Kidney Function between Gestational Hypertension and Preeclampsia.
Topics: Birth Weight; Creatine; Female; Fetal Development; Gestational Age; Glomerular Filtration Rate; Huma | 2017 |
Impact of maternal serum uric acid on perinatal outcome in women with hypertensive disorders of pregnancy: A prospective study.
Topics: Adult; Biomarkers; Female; Humans; Hypertension, Pregnancy-Induced; India; Infant, Newborn; Pre-Ecla | 2017 |
Maternal serum uric acid levels and blood pressure during pregnancy: A community-based cohort study.
Topics: Asymptomatic Diseases; Blood Pressure; Cohort Studies; Confounding Factors, Epidemiologic; Down-Regu | 2018 |
Strontium and its role in preeclampsia.
Topics: Adult; Biomarkers; Calcium; Case-Control Studies; Female; Gestational Age; Humans; Hypertension, Pre | 2018 |
The value of serum uric acid in predicting adverse pregnancy outcomes of women with hypertensive disorders of pregnancy.
Topics: Adult; Biomarkers; Case-Control Studies; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Pr | 2018 |
Maternal Serum Uric Acid as a Predictor of Severity of Hypertensive Disorders of Pregnancy: A Prospective Cohort Study.
Topics: Adult; Biomarkers; Blood Pressure; Female; Follow-Up Studies; Gestational Age; Humans; Hypertension, | 2019 |
Increased serum strontium levels and altered oxidative stress status in early-onset preeclampsia.
Topics: Adult; Age of Onset; Biomarkers; Creatinine; Diagnosis, Differential; Female; Fetal Growth Retardati | 2019 |
Coagulation/fibrinolysis and laboratory characteristics of pregnant women with severely depressed antithrombin activity.
Topics: Antithrombins; Blood Coagulation Disorders; Creatinine; Female; Fibrin Fibrinogen Degradation Produc | 2013 |
Maternal venous hemodynamics in gestational hypertension and preeclampsia.
Topics: Adult; Blood Pressure; Cardiography, Impedance; Cross-Sectional Studies; Echocardiography, Doppler; | 2014 |
Uric Acid Determination in Gestational Hypertension: Is it as Effective a Delineator of Risk as Proteinuria in High-Risk Women?
Topics: Adolescent; Adult; Biomarkers; Clinical Trials as Topic; Female; Gestational Age; Humans; Hypertensi | 2015 |
Independent Determinants of Maternal and Fetal Outcomes in a Sample of Pregnant Outpatients With Normal Blood Pressure, Chronic Hypertension, Gestational Hypertension, and Preeclampsia.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Body Mass Index; Female; Humans; Hypertension, Pregn | 2015 |
Uric Acid: A Missing Link Between Hypertensive Pregnancy Disorders and Future Cardiovascular Disease?
Topics: Adult; Biomarkers; Black People; Cardiovascular Diseases; Causality; Comorbidity; Cross-Sectional St | 2015 |
Does uric acid provide information about maternal condition and fetal outcome in pregnant women with hypertension?
Topics: Adult; Birth Weight; Blood Pressure; Creatinine; Female; Gestational Age; Humans; Hypertension, Preg | 2008 |
Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women.
Topics: Adult; Birth Weight; Blood Glucose; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnanc | 2009 |
Serum urea and uric acid concentration in pregnant women in sub-urban commercial community in Africa.
Topics: Adult; Female; Humans; Hypertension, Pregnancy-Induced; Nigeria; Pregnancy; Reference Values; Urea; | 2009 |
Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension.
Topics: Adolescent; Adult; Blood Pressure; Female; Fetal Growth Retardation; Gestational Age; Humans; Hypert | 2010 |
First trimester uric acid and adverse pregnancy outcomes.
Topics: Adult; Female; Humans; Hypertension, Pregnancy-Induced; Hyperuricemia; Infant, Newborn; Infant, Smal | 2011 |
Prognostic significance of serum uric acid in women with gestational hypertension.
Topics: Adult; Biomarkers; Blood Pressure; Female; Follow-Up Studies; Gestational Age; Humans; Hypertension, | 2011 |
Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension.
Topics: Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Infant, Low Birth Weight; Pre-Ecla | 2011 |
Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study.
Topics: Adult; Algorithms; Antioxidants; Australia; Biomarkers; Cohort Studies; Female; Hematocrit; Hemoglob | 2012 |
Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies.
Topics: Adult; Biomarkers; Blood Pressure; Cohort Studies; Disease Progression; Female; Gestational Age; Hum | 2012 |
Correlation of biochemical parameters and neonatal outcome in patients with gestational hypertension.
Topics: Apgar Score; Blood Glucose; Case-Control Studies; Creatinine; Female; HELLP Syndrome; Humans; Hypert | 2013 |
Early diagnosis of trophoblast produced capillary hypertension (pregnancy-induced hypertension).
Topics: Capillaries; Case-Control Studies; Early Diagnosis; Female; Hematocrit; Humans; Hypertension, Pregna | 2004 |
Elevated serum uric acid levels in gestational hypertension are correlated with insulin resistance.
Topics: Adult; Body Mass Index; Creatinine; Female; Homeostasis; Humans; Hypertension, Pregnancy-Induced; In | 2005 |
Evaluation of natural coagulation inhibitor levels in various hypertensive states of pregnancy.
Topics: Adult; Blood Coagulation Factor Inhibitors; Chronic Disease; Female; Humans; Hypertension; Hypertens | 2005 |
Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia.
Topics: Adolescent; Adult; Cells, Cultured; Female; Humans; Hypertension, Pregnancy-Induced; Lipopolysacchar | 2007 |